143 related articles for article (PubMed ID: 16758382)
21. Piperacillin-tazobactam versus ciprofloxacin plus amoxicillin in the treatment of infective episodes after liver transplantation.
Philpott-Howard J; Burroughs A; Fisher N; Hastings M; Kibbler C; Mutimer D; Patch D; Rolando N; Wade J; Wendon J; O'Grady J
J Antimicrob Chemother; 2003 Dec; 52(6):993-1000. PubMed ID: 14585863
[TBL] [Abstract][Full Text] [Related]
22. In vitro and in vivo activities of piperacillin-tazobactam and meropenem at different inoculum sizes of ESBL-producing Klebsiella pneumoniae.
Harada Y; Morinaga Y; Kaku N; Nakamura S; Uno N; Hasegawa H; Izumikawa K; Kohno S; Yanagihara K
Clin Microbiol Infect; 2014 Nov; 20(11):O831-9. PubMed ID: 24813594
[TBL] [Abstract][Full Text] [Related]
23. Piperacillin/tazobactam compared with cefuroxime/ metronidazole in the treatment of intra-abdominal infections.
Ohlin B; Cederberg A; Forssell H; Solhaug JH; Tveit E
Eur J Surg; 1999 Sep; 165(9):875-84. PubMed ID: 10533765
[TBL] [Abstract][Full Text] [Related]
24. [Controlled, open, parallel-group study of the clinical and microbiological efficacy of piperacillin-tazobactam versus metronidazole + gentamicin in urgent colorectal surgery].
Ferrer J; Fondevila C; Bombuy E; Fuster J; Alvarez G; Charco R; García-Valdecasas JC
Cir Esp; 2006 Jun; 79(6):365-9. PubMed ID: 16769001
[TBL] [Abstract][Full Text] [Related]
25. General microbiology and in vitro susceptibility of anaerobes isolated from complicated skin and skin-structure infections in patients enrolled in a comparative trial of ertapenem versus piperacillin-tazobactam.
Goldstein EJ; Citron DM; Merriam CV; Warren Y; Tyrrell KL; Gesser RM
Clin Infect Dis; 2002 Sep; 35(Suppl 1):S119-25. PubMed ID: 12173120
[TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness of ceftolozane/tazobactam plus metronidazole compared with piperacillin/tazobactam as empiric therapy for the treatment of complicated intra-abdominal infections based on the in-vitro surveillance of bacterial isolates in the UK.
Prabhu V; Foo J; Ahir H; Sarpong E; Merchant S
J Med Econ; 2017 Aug; 20(8):840-849. PubMed ID: 28532194
[TBL] [Abstract][Full Text] [Related]
27. Piperacillin/tazobactam in the treatment of Klebsiella pneumoniae infections in neonates.
Pillay T; Pillay DG; Adhikari M; Sturm AW
Am J Perinatol; 1998 Jan; 15(1):47-51. PubMed ID: 9475688
[TBL] [Abstract][Full Text] [Related]
28. Piperacillin-Tazobactam Usage at a Tertiary Pediatric Hospital: An Antimicrobial Stewardship Review.
Janowski AB; Michaels MG; Martin JM; Green MD
J Pediatric Infect Dis Soc; 2016 Sep; 5(3):342-5. PubMed ID: 26407269
[TBL] [Abstract][Full Text] [Related]
29. Clinical efficacy of piperacillin/tazobactam in the treatment of complicated skin and soft tissue infections.
Takimoto K; Wang Q; Suzuki D; Katayama M; Hayashi Y
Expert Opin Pharmacother; 2017 Jul; 18(10):1027-1034. PubMed ID: 28627952
[TBL] [Abstract][Full Text] [Related]
30. Antibiotic Prophylaxis with Piperacillin-Tazobactam Reduces Post-Operative Infectious Complication after Pancreatic Surgery: An Interventional, Non-Randomized Study.
De Pastena M; Paiella S; Azzini AM; Zaffagnini A; Scarlini L; Montagnini G; Maruccio M; Filippini C; Romeo F; Mazzariol A; Cascio GL; Bazaj A; Secchettin E; Bassi C; Salvia R
Surg Infect (Larchmt); 2021 Jun; 22(5):536-542. PubMed ID: 33095107
[No Abstract] [Full Text] [Related]
31. [Randomized, prospective and comparative clinical trial of piperacillin/tazobactam versus ceftriaxone plus ornidazole in the treatment of biliary tract infections].
Sirvent JM; Rodríguez JI; Rodríguez I; García-Oria M; Roig J; Bonet A
Med Clin (Barc); 2003 Dec; 121(20):761-5. PubMed ID: 14697160
[TBL] [Abstract][Full Text] [Related]
32. Piperacillin/tazobactam in comparison with clindamycin plus gentamicin in the treatment of intra-abdominal infections.
Shyr YM; Lui WY; Su CH; Wang LS; Liu CY
Zhonghua Yi Xue Za Zhi (Taipei); 1995 Aug; 56(2):102-8. PubMed ID: 7553416
[TBL] [Abstract][Full Text] [Related]
33. Retrospective evaluation of piperacillin-tazobactam, imipenem-cilastatin and meropenem used on surgical floors at a tertiary care hospital in Saudi Arabia.
Youssif E; Aseeri M; Khoshhal S
J Infect Public Health; 2018; 11(4):486-490. PubMed ID: 29153444
[TBL] [Abstract][Full Text] [Related]
34. Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infections.
Perry CM; Markham A
Drugs; 1999 May; 57(5):805-43. PubMed ID: 10353303
[TBL] [Abstract][Full Text] [Related]
35. Experience with the use of piperacillin-tazobactam in pediatric non-renal solid organ transplantation.
Wiesmayr S; Stelzmueller I; Mark W; Muehlmann G; Tabarelli W; Tabarelli D; Laesser R; Antretter H; Ladurner R; Zimmerhackl LB; Margreiter R; Guggenbichler JP; Bonatti H
Pediatr Transplant; 2007 Feb; 11(1):38-48. PubMed ID: 17239122
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of piperacillin-tazobactam in the treatment of surgical wound infection after clean-contaminated head and neck oncologic surgery.
Rodrigo JP; Sŭrez C; Bernaldez R; Collado D
Head Neck; 2004 Sep; 26(9):823-8. PubMed ID: 15350029
[TBL] [Abstract][Full Text] [Related]
37. Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum β-lactamase bacteremia.
Tamma PD; Han JH; Rock C; Harris AD; Lautenbach E; Hsu AJ; Avdic E; Cosgrove SE;
Clin Infect Dis; 2015 May; 60(9):1319-25. PubMed ID: 25586681
[TBL] [Abstract][Full Text] [Related]
38. Occurrence of ESBL & Amp-C beta-lactamases & susceptibility to newer antimicrobial agents in complicated UTI.
Taneja N; Rao P; Arora J; Dogra A
Indian J Med Res; 2008 Jan; 127(1):85-8. PubMed ID: 18316858
[TBL] [Abstract][Full Text] [Related]
39. In the literature. Piperacillin-tazobactam and extended-spectrum β-lactamase--producing Escherichia coli.
Clin Infect Dis; 2013 Nov; 57(10):iii-iv. PubMed ID: 24308040
[No Abstract] [Full Text] [Related]
40. Characterization of Piperacillin/Tazobactam-Resistant Klebsiella oxytoca Recovered from a Nosocomial Outbreak.
Fujita A; Kimura K; Yokoyama S; Jin W; Wachino J; Yamada K; Suematsu H; Yamagishi Y; Mikamo H; Arakawa Y
PLoS One; 2015; 10(11):e0142366. PubMed ID: 26539828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
